Biotech News
Supernus to Participate in the 2025 Jefferies Global Healthcare Conference in London
ir.supernus.com2026-05-06 15:28 EST
ROCKVILLE, Md. , Nov. 12, 2025 (GLOBE NEWSWIRE) -- Supernus Pharmaceuticals, Inc. (Nasdaq: SUPN), a biopharmaceutical company focused on developing and commercializing products for the treatment of central nervous system (CNS) diseases, announced today that Jack A.